AbadA., NavarroM., SastreJ.: UFT plus oral folinic acid as therapy for metastatic colorectal cancer in older patients. Oncology, 11: 53–57, 1997.
2.
CarmichaelJ., PopolaT., RadstoneD.: Randomized comparative study of Orzel versus 5FU plus leucovorin in patients with metastatic colorectal cancer. Proc ASCO, 18: 264a, 1999.
3.
Diaz-RubioE., SastreJ., AbadA.: UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients. Oncology, 13: 35–40, 1999.
4.
ExtermannM.: Measuring comorbidity in older cancer patients. Eur J Cancer, 36: 453–471, 2000.
5.
FeliuJ., Gonzales BaronM., EspinosaE.: Uracil and tegafur modulated with leucovorin. An effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group. Cancer, 79: 1884–1889, 1997.
6.
FentimanI.S., TirelliU., MonfardiniS.: Cancer in the elderly: why so badly treated?Lancet, 335: 1020–1022, 1990.
7.
KaneR.A., KaneR.L.: Assessing the elderly: a practical guide to measurement.Lexington Massachussets, DC Health, 1981.
8.
LiuG., FranssenE., FitchM.: Patient preference for oral versus intravenous palliative chemotherapy. J Clin Oncol, 15; 100–115:1997.
9.
PazdurR.: A phase II trial of uracile and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma. J Clin Oncol, 12: 2296–2300, 1994.
10.
PazdurR., DouillardJ.Y., SkillingJ.: Multicenter phase III study of 5FU or UFT in combination with leucovorin in patients with metastatic colorectal cancer. Proc ASCO, 18: 263a, 1999.
